1. Home
  2. ACOG vs STIM Comparison

ACOG vs STIM Comparison

Compare ACOG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • STIM
  • Stock Information
  • Founded
  • ACOG 2000
  • STIM 2003
  • Country
  • ACOG Canada
  • STIM United States
  • Employees
  • ACOG N/A
  • STIM N/A
  • Industry
  • ACOG
  • STIM Medical/Dental Instruments
  • Sector
  • ACOG
  • STIM Health Care
  • Exchange
  • ACOG Nasdaq
  • STIM Nasdaq
  • Market Cap
  • ACOG 91.6M
  • STIM 192.0M
  • IPO Year
  • ACOG N/A
  • STIM 2018
  • Fundamental
  • Price
  • ACOG $6.03
  • STIM $4.36
  • Analyst Decision
  • ACOG
  • STIM Buy
  • Analyst Count
  • ACOG 0
  • STIM 4
  • Target Price
  • ACOG N/A
  • STIM $4.67
  • AVG Volume (30 Days)
  • ACOG 103.6K
  • STIM 1.7M
  • Earning Date
  • ACOG 11-15-2024
  • STIM 03-04-2025
  • Dividend Yield
  • ACOG N/A
  • STIM N/A
  • EPS Growth
  • ACOG N/A
  • STIM N/A
  • EPS
  • ACOG N/A
  • STIM N/A
  • Revenue
  • ACOG N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • ACOG N/A
  • STIM $3.23
  • Revenue Next Year
  • ACOG N/A
  • STIM $29.55
  • P/E Ratio
  • ACOG N/A
  • STIM N/A
  • Revenue Growth
  • ACOG N/A
  • STIM 5.03
  • 52 Week Low
  • ACOG $4.66
  • STIM $0.52
  • 52 Week High
  • ACOG $7.00
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • STIM 73.44
  • Support Level
  • ACOG N/A
  • STIM $2.80
  • Resistance Level
  • ACOG N/A
  • STIM $3.65
  • Average True Range (ATR)
  • ACOG 0.00
  • STIM 0.47
  • MACD
  • ACOG 0.00
  • STIM 0.06
  • Stochastic Oscillator
  • ACOG 0.00
  • STIM 89.01

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: